147 related articles for article (PubMed ID: 10388984)
1. Effect of hyperketonemia on plasma lipid peroxidation levels in diabetic patients.
Jain SK; McVie R; Jackson R; Levine SN; Lim G
Diabetes Care; 1999 Jul; 22(7):1171-5. PubMed ID: 10388984
[TBL] [Abstract][Full Text] [Related]
2. Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients.
Jain SK; McVie R
Diabetes; 1999 Sep; 48(9):1850-5. PubMed ID: 10480618
[TBL] [Abstract][Full Text] [Related]
3. Hyperketonemia (acetoacetate) increases the oxidizability of LDL + VLDL in Type-I diabetic patients.
Jain SK; McVie R; Jaramillo JJ; Chen Y
Free Radic Biol Med; 1998 Jan; 24(1):175-81. PubMed ID: 9436628
[TBL] [Abstract][Full Text] [Related]
4. Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes.
Jain SK; Kannan K; Lim G; Matthews-Greer J; McVie R; Bocchini JA
Diabetes Care; 2003 Jul; 26(7):2139-43. PubMed ID: 12832326
[TBL] [Abstract][Full Text] [Related]
5. Point of care blood ketone testing of diabetic patients in the emergency department.
Bektas F; Eray O; Sari R; Akbas H
Endocr Res; 2004 Aug; 30(3):395-402. PubMed ID: 15554356
[TBL] [Abstract][Full Text] [Related]
6. Accuracy of an electrochemical sensor for measuring capillary blood ketones by fingerstick samples during metabolic deterioration after continuous subcutaneous insulin infusion interruption in type 1 diabetic patients.
Guerci B; Benichou M; Floriot M; Bohme P; Fougnot S; Franck P; Drouin P
Diabetes Care; 2003 Apr; 26(4):1137-41. PubMed ID: 12663586
[TBL] [Abstract][Full Text] [Related]
7. Hyperketonemia increases tumor necrosis factor-alpha secretion in cultured U937 monocytes and Type 1 diabetic patients and is apparently mediated by oxidative stress and cAMP deficiency.
Jain SK; Kannan K; Lim G; McVie R; Bocchini JA
Diabetes; 2002 Jul; 51(7):2287-93. PubMed ID: 12086962
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of ketosis, ketonuria, and ketoacidosis during liberal glycemic control in critically ill patients with diabetes: an observational study.
Luethi N; Cioccari L; Crisman M; Bellomo R; Eastwood GM; Mårtensson J
Crit Care; 2016 Sep; 20():297. PubMed ID: 27633987
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Traub formula and ketone bodies in cause of death investigations.
Keltanen T; Sajantila A; Palo JU; Partanen T; Valonen T; Lindroos K
Int J Legal Med; 2013 Nov; 127(6):1131-7. PubMed ID: 24091723
[TBL] [Abstract][Full Text] [Related]
10. Ketone body production and disposal in diabetic ketosis. A comparison with fasting ketosis.
Féry F; Balasse EO
Diabetes; 1985 Apr; 34(4):326-32. PubMed ID: 3918903
[TBL] [Abstract][Full Text] [Related]
11. Oxidative markers in diabetic ketoacidosis.
Vantyghem MC; Balduyck M; Zerimech F; Martin A; Douillard C; Bans S; Degand PM; Lefebvre J
J Endocrinol Invest; 2000 Dec; 23(11):732-6. PubMed ID: 11194706
[TBL] [Abstract][Full Text] [Related]
12. Ketone body kinetics in humans: the effects of insulin-dependent diabetes, obesity, and starvation.
Hall SE; Wastney ME; Bolton TM; Braaten JT; Berman M
J Lipid Res; 1984 Nov; 25(11):1184-94. PubMed ID: 6440941
[TBL] [Abstract][Full Text] [Related]
13. Blood ketone bodies in patients with recent-onset type 1 diabetes (a multicenter study).
Prisco F; Picardi A; Iafusco D; Lorini R; Minicucci L; Martinucci ME; Toni S; Cerutti F; Rabbone I; Buzzetti R; Crino A; Pozzilli P
Pediatr Diabetes; 2006 Aug; 7(4):223-8. PubMed ID: 16911010
[TBL] [Abstract][Full Text] [Related]
14. Measurement of β-hydroxybutyrate in cats with nonketotic diabetes mellitus, diabetic ketosis, and diabetic ketoacidosis.
Weingart C; Lotz F; Kohn B
J Vet Diagn Invest; 2012 Mar; 24(2):295-300. PubMed ID: 22362525
[TBL] [Abstract][Full Text] [Related]
15. The hospital and home use of a 30-second hand-held blood ketone meter: guidelines for clinical practice.
Wallace TM; Meston NM; Gardner SG; Matthews DR
Diabet Med; 2001 Aug; 18(8):640-5. PubMed ID: 11553201
[TBL] [Abstract][Full Text] [Related]
16. Advantages to using capillary blood beta-hydroxybutyrate determination for the detection and treatment of diabetic ketosis.
Guerci B; Tubiana-Rufi N; Bauduceau B; Bresson R; Cuperlier A; Delcroix C; Durain D; Fermon C; Le Floch JP; Le Devehat C; Melki V; Monnier L; Mosnier-Pudar H; Taboulet P; Hanaire-Broutin H
Diabetes Metab; 2005 Sep; 31(4 Pt 1):401-6. PubMed ID: 16369204
[TBL] [Abstract][Full Text] [Related]
17. Effect of hyperketonemia on blood monocytes in type-I diabetic patients and apoptosis in cultured U937 monocytes.
Jain SK; Kannan K; McVie R
Antioxid Redox Signal; 1999; 1(2):211-20. PubMed ID: 11228748
[TBL] [Abstract][Full Text] [Related]
18. Can serum beta-hydroxybutyrate be used to diagnose diabetic ketoacidosis?
Sheikh-Ali M; Karon BS; Basu A; Kudva YC; Muller LA; Xu J; Schwenk WF; Miles JM
Diabetes Care; 2008 Apr; 31(4):643-7. PubMed ID: 18184896
[TBL] [Abstract][Full Text] [Related]
19. Ketosis (acetoacetate) can generate oxygen radicals and cause increased lipid peroxidation and growth inhibition in human endothelial cells.
Jain SK; Kannan K; Lim G
Free Radic Biol Med; 1998 Dec; 25(9):1083-8. PubMed ID: 9870562
[TBL] [Abstract][Full Text] [Related]
20. Evidence for a role for insulin and growth hormone in overnight regulation of 3-hydroxybutyrate in normal and diabetic adolescents.
Edge JA; Harris DA; Phillips PE; Pal BR; Matthews DR; Dunger DB
Diabetes Care; 1993 Jul; 16(7):1011-8. PubMed ID: 8359093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
